Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary
Kidney360 · 04.06.2026
DOI: 10.34067/kid.0000001279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 04.06.2026. Verfasst von William P Martin. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
ORCID-Profile: William P Martin
Zitieren
APA
Martin, W. P. (2026). Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary. Kidney360. https://doi.org/10.34067/kid.0000001279
Vancouver
Martin WP. Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary. Kidney360. 2026. doi:10.34067/kid.0000001279
BibTeX
@article{Martin2026,
author = {Martin, William P},
title = {Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary},
journal = {Kidney360},
year = {2026},
doi = {10.34067/kid.0000001279}
}
EUVIMED